Bio-Techne (TECH) FCF Margin (2009 - 2026)

Bio-Techne (TECH) recorded quarterly FCF Margin of 24.91% in Q1 2026, down 3.64% quarter-over-quarter from 25.85% in Q4 2025, and up 1511.0% on a YoY basis from 1.55% in Q1 2025.

Bio-Techne (TECH) FCF Margin (2009 - 2026) Analysis & Trends

Bio-Techne's FCF Margin history runs 18 years deep, the most recent figure standing at 24.91% for Q1 2026.

  • In Q1 2026, FCF Margin rose 1511.0% year-over-year to 24.91%; the TTM figure through Mar 2026 stood at 22.27% (up 400.0% YoY), while the FY2025 annual figure was 21.03%, up 66.0% from the prior year.
  • FCF Margin was 24.91% for Q1 2026 at Bio-Techne, down from 25.85% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 2326.25% in Q3 2022 to a low of 7.75% in Q3 2025.
  • Historically, FCF Margin has averaged 156.49% across 5 years, with a median of 21.46% in 2022.
  • The sharpest annual moves came in 2022 and 2023: FCF Margin jumped 230981 bps in 2022, then tumbled 230972 bps in 2023.
  • A 5-year view of FCF Margin shows it stood at 21.46% in 2022, then increased by 17 bps to 25.04% in 2023, then climbed by 4 bps to 26.1% in 2024, then slipped by 1 bps to 25.85% in 2025, then declined by 4 bps to 24.91% in 2026.
  • The last three FCF Margin figures came in at 24.91% (Q1 2026), 25.85% (Q4 2025), and 7.75% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -3.98%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 43.35%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Bio-Techne 9.04 Bn 8.83 Bn 208.29 Mn 24.91%

Historic Data

Download Data
DateValue
Mar 31, 2026 24.91%
Dec 31, 2025 25.85%
Sep 30, 2025 7.75%
Jun 30, 2025 29.44%
Mar 31, 2025 9.80%
Dec 31, 2024 26.10%
Sep 30, 2024 18.90%
Jun 30, 2024 18.79%
Mar 31, 2024 21.27%
Dec 31, 2023 25.04%
Sep 30, 2023 16.53%
Jun 30, 2023 24.08%
Mar 31, 2023 13.19%
Dec 31, 2022 21.46%
Sep 30, 2022 2,326.25%
Jun 30, 2022 30.93%
Mar 31, 2022 19.98%
Dec 31, 2021 33.73%
Sep 30, 2021 16.44%
Jun 30, 2021 42.74%